The importance of the day of embryo transfer during in vitro fertilisation
BMJ 2024; 386 doi: https://doi.org/10.1136/bmj.q1703 (Published 16 September 2024) Cite this as: BMJ 2024;386:q1703Linked Research
Cumulative live birth rate of a blastocyst versus cleavage stage embryo transfer policy during in vitro fertilisation in women with a good prognosis
Linked Editorial
Timing embryo transfers during assisted reproduction
- Simone Cornelisse, medical doctor1,
- Liliana Ramos, clinical embryologist1,
- Sebastiaan Mastenbroek, clinical embryologist23
- 1Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, Netherlands
- 2Amsterdam UMC, location University of Amsterdam, Centre for Reproductive Medicine, Amsterdam, Netherlands
- 3Amsterdam Reproduction and Development Research Institute, Amsterdam, Netherlands
- Correspondence to: S Cornelisse simone.cornelisse{at}radboudumc.nl
In vitro fertilisation (IVF) is a well established treatment for infertility and has been responsible for the birth of more than 10 million children worldwide since 1978.1 An IVF cycle includes ovarian hyperstimulation with hormones, oocyte retrieval, and then fertilisation and embryo culture in the laboratory.23 In most laboratories worldwide, embryos are cultured in vitro for three to six days, and the embryos with the highest chance of resulting in a live birth are selected for intrauterine transfer. Surplus embryos are cryopreserved for future use if a live birth is unsuccessful after an initial transfer or more children are planned.
Embryo development and transfer policies
IVF, with or without intracytoplasmic sperm injection (ICSI), involves the handling of sperm cells and oocytes (gametes) and embryos outside the human body. In IVF, thousands of sperm cells are used to inseminate oocytes in the laboratory, whereas in ICSI, one sperm cell is selected and injected into each oocyte.23 About 23 hours after fertilisation, the first cell division occurs. On the second day after insemination or injection, the embryo should comprise four cells (blastomeres), and on the third day the embryo ideally presents with eight equally sized blastomeres—although some embryos cleave a little faster, and some slower.
The cleavage stage of embryo development comprises the period from two cells to the morula stage, which occurs around day 4 of culture (fig 1). During the morula stage the embryo has around 16 cells, and then a process called compaction begins, where the cells start to adhere tightly to each other, forming a compacted structure. This process is crucial for the next stage of development, as it increases cell-to-cell communication and prepares the embryo for differentiation. Cell division increases exponentially. In the subsequent blastocyst stage, around day 5 or day 6 of embryo development, a fluid filled cavity called a blastocoele forms within the embryo, which now has more than 100 cells. Some cells differentiate into an inner cell mass, from which the fetus will eventually develop, and other cells form an outer layer of trophectoderm cells, which later in development will contribute to the placenta.3
Embryo transfer can occur at different stages of development. Traditionally, embryos were transferred on day 3 after insemination or sperm injection, aligning with the cleavage stage of embryo development. After improvements to in vitro culture conditions and embryo cryopreservation techniques, the standard practice has shifted towards transferring embryos at the blastocyst stage, usually on the fifth or sixth day after oocyte retrieval.456
Rationale behind transfer approaches
The rationale for embryo transfer at the blastocyst stage lies in the potential for an enhanced embryo selection process. In IVF, not all embryos develop into good quality blastocysts. Some embryos show arrested development and some exhibit lower implantation potential, as can be observed in the laboratory by morphological characteristics such as the presence of too few or too many cells during development, and the presence of cell fragments. Extended culture to the blastocyst stage helps in identifying embryos with high implantation potential. Moreover, transferring embryos at the blastocyst stage is thought to align more closely with the natural timing of implantation in the endometrium, potentially increasing the chance of live birth for each transfer and reducing the number of embryo transfers needed to achieve pregnancy.456
Committing to a blastocyst stage transfer carries the risk of poor embryo development, however, as debate is still ongoing about whether IVF culture conditions are truly optimised for human embryos. Embryos that might not survive the challenges of extended in vitro culture might survive in vivo if transferred to the uterus at the cleavage stage. Additionally, the number of supernumerary embryos available for cryopreservation at the cleavage stage is typically higher than those available after reaching the blastocyst stage.4
Cumulative live birth rate
Success rates in IVF are increasingly measured by the cumulative live birth rate, which includes live births from all fresh and frozen-thawed embryo transfers resulting from a single oocyte retrieval. This metric better provides a more comprehensive reflection of the overall success rate of an IVF treatment cycle. Traditionally, IVF success rates were reported based on the live births for each fresh or first embryo transfer, excluding the outcomes of supernumerary frozen-thawed embryo transfers. With advances in cryopreservation methods, the success of embryo freezing and thawing has increased considerably, leading to higher cumulative live birth rates.7 Today, both professionals and women consider it essential to report outcomes from both fresh and frozen-thawed embryo transfers to obtain a better idea of the true success of an IVF treatment.89
Key findings and interpretation
Despite the widespread adoption of blastocyst stage embryo transfer in IVF practices globally, it remained unclear whether a blastocyst stage policy actually improved cumulative live birth rates.4 In our study (doi:10.1136/bmj-2024-080133), we compared the cumulative live birth rates between blastocyst stage and cleavage stage embryo transfers.10 The similar cumulative live birth rates observed in our study underscore the importance of considering other factors when choosing between cleavage stage and blastocyst stage embryo transfers for women with a good prognosis. Although blastocyst stage embryo transfer may enhance treatment efficiency by reducing the number of unnecessary transfers, and might lower miscarriage rates, the increased risk of preterm birth necessitates careful evaluation.10
Footnotes
Funding and competing interests available in the linked paper on bmj.com.
Provenance and peer review: Commissioned; not externally peer reviewed.